- A staff member works at a workshop of Flender Ltd., China.
- Eyeing China’s huge and more open market, comprehensive industrial system, and improved business environment, many foreign-funded businesses are doubling down on their investments in the world’s second-largest economy.
- The Tianjin facility is not only one of its strategic manufacturing sites but also its only provider of durable insulin injection devices and its largest insulin production site.
Why foreign enterprises double down on investment in China
